Gastroenterology

Researchers have uncovered an antibiotic therapy that provides continuing relief for IBS for up to 10 weeks, according to a study in NEJM.

Issues of health literacy and numeracy come into play when identifying the best strategies for explaining the risk associated with treatments for IBD.

Esophageal cancer risk in patients with GERD is not as pronounced as once thought; the rate in women is similar to that of breast cancer in men.

Nearly one in five patients suffering from Crohn's disease were found to have mental health status indicative of PTSD.

Updated AAD position statement addresses studies showing possible link between isotretinoin use and depression and/or inflammatory bowel disease.

A review of the data on risk of infection, malignancy, and death associated with therapies for IBD.

The need exists to achieve maximum efficieny in the endo suite while maintaining maximum qualty.

Seven poster presentations focused on ulcerative colitis during the Monday, October 18, poster presentations. Here, each is summarized.

Of the nearly 400 clinical vignettes and case reports presented on Monday, two focused on ulcerative colitis.

ACG unveils enhanced version of GI Circle based on member feedback.

What evidence exists to support the use of antidepressants in patients with irritable bowel syndrome.

Boston University researchers are recruiting Chron's and gastric bypass patients on which to test a fluorescent lamp capable of producing vitamin D in the skin.

Researchers in Turkey have found that the anesthetic levobupivacaine reduces inflammation at sites in the colon that is caused by IBD.

This recent comment from a patient during an exam led Dr. Pullen to reflect on the many things that physicians do during an office visit that may seem odd to patients.

Ciaran P. Kelly, Associate Professor, Harvard Medical School discusses common and uncommon issues related to swallowing.

Recent findings from researchers at the Nationwide Children's Hospital show that not only are infants who are born with complex congenital heart disease at risk for serious heart-related complications, they are also at risk for developing necrotizing enterocolitis

The side effects that may occur as a result of stopping clopidogrel are much more serious than the slightly increased bleeding risk that patients on clopidogrel are faced with.

Researchers at the University of California, San Diego, School of Medicine have discovered that common intestinal bacteria may promote tumor growth, but that introduction an inhibiting protein enzyme can prevent this promotion.

In a preliminary study, Attiva, increased the post-meal feeling of satiety and reduced hunger between meals.

Using an evidence-based practice approach, researchers have developed new diagnostic algorithms that will provide diagnostic pathways for common symptoms like diarrhea, nausea and vomiting, abdominal pain, and constipation.

The prevalence of abused children experiencing unexplained early development of gastrointestinal symptoms was the focus of a study published in the Annals of Family Medicine (March/April 2010).

There's a concept in healthcare insurance where all risks in a community of interest, a market, are pooled - community rating; and then there's experience rating where the healthy are advantaged in more ways then one and the sick are marginalized, paying disproportionately more into the pool just to have a seat at the table.

Splenic artery aneurysm is the most common form of visceral artery aneurysm. Most present asymptomatically with incidental findings on CT or ultrasound which are diagnostic, although about 20% present with vague left upper quadrant abdominal pain. Treatment should be aimed at preserving splenic function whenever possible and endovascular treatments offer a less invasive option to patients than open surgical ligation or resection.

With gluten-free diets very challenging to stick to, Rush University Medical Center (RUMC) gastroenterologists are studying the use of mind/body techniques to help patients stick to the strict diet.

Mayo Clinic researchers have found that St. John's wort is not effective at treating irritable bowel syndrome.